Stoke Therapeutics Future Growth

How is Stoke Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

6.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:STOK - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	27	-143	-154	N/A	6
12/31/2024	13	-141	-144	-148	7
12/31/2023	10	-122	-115	-106	11
9/30/2022	9	-100	-30	-26	N/A
6/30/2022	6	-96	-20	-18	N/A
3/31/2022	3	-94	-16	-14	N/A
12/31/2021	N/A	-86	-68	-67	N/A
9/30/2021	N/A	-76	-63	-62	N/A
6/30/2021	N/A	-67	-59	-58	N/A
3/31/2021	N/A	-58	-52	-52	N/A
12/31/2020	N/A	-52	-43	-42	N/A
9/30/2020	N/A	-48	-43	-41	N/A
6/30/2020	N/A	-43	-41	-39	N/A
3/31/2020	N/A	-38	-37	-35	N/A
12/31/2019	N/A	-32	-33	-31	N/A
9/30/2019	N/A	-26	-26	-24	N/A
6/30/2019	N/A	-21	-20	-19	N/A
3/31/2019	N/A	-16	-17	-16	N/A
12/31/2018	N/A	-13	-12	-11	N/A

Earnings vs Savings Rate: STOK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: STOK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: STOK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: STOK's revenue (53.5% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: STOK's revenue (53.5% per year) is forecast to grow faster than 20% per year.